NCT00798070 2024-12-18PANTHERKarolinska University HospitalPhase 3 Active not recruiting2,017 enrolled
NCT01788020 2024-05-13Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's MacroglobulinemiaUniversity of UlmPhase 3 Completed202 enrolled
NCT02032277 2021-01-20A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast CancerAbbViePhase 3 Completed634 enrolled
NCT00083551 2015-11-23UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation ChemotherapyUniversity of ArkansasPhase 3 Completed668 enrolled 7 charts
NCT00109031 2014-09-15Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)Swedish Orphan BiovitrumPhase 3 Completed47 enrolled 19 charts
NCT00813150 2014-08-15Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple MyelomaJanssen-Cilag G.m.b.HPhase 3 Completed96 enrolled 12 charts
NCT00004230 2012-06-06Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell TransplantationNorthwestern UniversityPhase 3 Completed35 enrolled